Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Total Non-Current Liabilities (2024 - 2025)

Carlsmed's Total Non-Current Liabilities history spans 2 years, with the latest figure at $30.9 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 20.07% year-over-year to $30.9 million; the TTM value through Dec 2025 reached $30.9 million, up 20.07%, while the annual FY2025 figure was $30.9 million, 20.07% up from the prior year.
  • Total Non-Current Liabilities reached $30.9 million in Q4 2025 per CARL's latest filing, up from $28.2 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $30.9 million in Q4 2025 to a low of $25.8 million in Q4 2024.